Apollomics APLM
NASDAQ APLM
$23.86 -1.02 (-4.04%)
As of: Sep 10, 2026 · 11:04 AM EDT

Apollomics (APLM) Total Current Liabilities (2021 - 2025)

Apollomics' (APLM) quarterly Total Current Liabilities came in at $388000.0 in Q4 2025, down 93.19% year-over-year from $5.7 million in Q4 2024, and down 40.03% quarter-over-quarter from $647000.0 in Q2 2025.

Analysis

Apollomics (APLM) Total Current Liabilities (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Total Current Liabilities for 5 consecutive years, with $388000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 93.19% year-over-year to $388000.0 in Q4 2025; TTM through Dec 2025 was $388000.0, a 93.19% decrease from a year earlier, with the FY2025 full-year figure at $388000.0, down 93.19% from the prior year.
  • Total Current Liabilities was $388000.0 for Q4 2025 at Apollomics, down from $647000.0 in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $109.9 million in Q4 2021 and troughed at $388000.0 in Q4 2025.
  • A 5-year average of $37.7 million and a median of $31.9 million in 2023 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities plunged 34.76% in 2023 and slumped 97.05% in 2025, its largest moves.
  • Over 5 years, Total Current Liabilities stood at $109.9 million in 2021, then slumped by 41.65% to $64.1 million in 2022, then sank by 34.76% to $41.8 million in 2023, then plunged by 86.38% to $5.7 million in 2024, then plunged by 93.19% to $388000.0 in 2025.
  • The last three Total Current Liabilities figures came in at $388000.0 (Q4 2025), $647000.0 (Q2 2025), and $5.7 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 283.60 Mn
10 Apollomics 34.50 Mn 31.23 Mn - 388,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 388,000.00
Jun 30, 2025 647,000.00
Dec 31, 2024 5.70 Mn
Jun 30, 2024 21.92 Mn
Dec 31, 2023 41.83 Mn
Jun 30, 2023 57.24 Mn
Dec 31, 2022 64.12 Mn
Dec 31, 2021 109.88 Mn